{"id":"W4281666844","doi":"10.1200/jco.2022.40.16_suppl.tps5623","title":"KEYNOTE-C93/GOG-3064/ENGOT-en15: A phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Medicine; Chemotherapy; Pembrolizumab; Internal medicine; Endometrial cancer; Oncology; Docetaxel; Paclitaxel; Randomization; Trastuzumab; Cancer; Surgery; Cisplatin; Randomized controlled trial; Breast cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002654071,0.002096015,0.001719529,0.0005339798,0.0005017835,0.001143842,0.001710118,0.002444155,0.01084249],"category_scores_gemma":[0.001413102,0.0007189407,0.00155592,0.0004390551,0.001030099,0.001288241,0.0004497533,0.004353572,0.001874993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001831592,"about_ca_system_score_gemma":0.002280154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002553106,"about_ca_topic_score_gemma":0.009247086,"domain_scores_codex":[0.9994358,0.0002921329,0.00001968186,0.0000940071,0.00004900082,0.0001093464],"domain_scores_gemma":[0.9991407,0.0001534695,0.0002148064,0.00005504439,0.00006230343,0.000373734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9064995,0.03468152,0.001364656,0.001212194,0.001182779,0.0001294231,0.0001454998,0.001006838,0.01113864,0.0004355681,0.00744734,0.03475608],"study_design_scores_gemma":[0.909283,0.08518136,0.001809857,0.00005167018,0.0002692768,0.00007822923,0.00003327324,0.0004804325,0.00059671,0.0001885921,0.002008144,0.00001942389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9581552,0.006504862,0.00138708,0.001946569,0.0007303778,0.01692663,0.006903251,0.0004463581,0.006999851],"genre_scores_gemma":[0.9554313,0.003748494,0.004610823,0.005211227,0.0003734487,0.0149877,0.006083402,0.0001103904,0.009443181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01084249,"threshold_uncertainty_score":0.03627181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2472120266613455,"score_gpt":0.5099421291822217,"score_spread":0.2627301025208763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}